Published in Neurorehabil Neural Repair on May 15, 2012
Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol (2015) 0.99
Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease. J Neurol (2016) 0.77
High-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Functional Recovery by Enhancing Neurogenesis and Activating BDNF/TrkB Signaling in Ischemic Rats. Int J Mol Sci (2017) 0.75
Novel Neuromodulation Techniques to Assess Interhemispheric Communication in Neural Injury and Neurodegenerative Diseases. Front Neural Circuits (2017) 0.75
Theta burst stimulation over premotor cortex in Parkinson's disease: an explorative study on manual dexterity. J Neural Transm (Vienna) (2016) 0.75
The effects of 1 Hz rTMS preconditioned by tDCS on gait kinematics in Parkinson's disease. J Neural Transm (Vienna) (2014) 0.75
Theta burst stimulation of the human motor cortex. Neuron (2005) 8.33
Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J Neurosci (2001) 3.18
Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord (2000) 2.70
High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance. J Neurosci (2008) 2.65
Disturbance of sequential movements in patients with Parkinson's disease. Brain (1987) 2.30
Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease. Eur J Neurosci (2006) 2.29
Abnormal oscillatory synchronisation in the motor system leads to impaired movement. Curr Opin Neurobiol (2008) 2.28
New insights into rhythmic brain activity from TMS-EEG studies. Trends Cogn Sci (2009) 2.05
Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol (1995) 2.03
Transcranial direct current stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry (2010) 1.93
Excessive synchronization of basal ganglia neurons at 20 Hz slows movement in Parkinson's disease. Exp Neurol (2007) 1.80
High-frequency stimulation in Parkinson's disease: more or less? Trends Neurosci (2005) 1.59
Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain (2006) 1.53
Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry (2005) 1.46
Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Mov Disord (2006) 1.26
Effects of internal globus pallidus stimulation on motor cortex excitability. Neurology (2001) 1.25
Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease. Clin Neurophysiol (2004) 1.22
Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation. Neuroimage (2006) 1.21
Effect of transcranial magnetic stimulation on Parkinson motor function--systematic review of controlled clinical trials. Mov Disord (2009) 1.20
Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study. Eur J Neurosci (2005) 1.17
Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease. Mov Disord (2006) 1.16
Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 1.10
Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation. Brain (1996) 1.06
Transcranial magnetic stimulation and Parkinson's disease. Brain Res Brain Res Rev (2002) 1.02
Abnormal excitability of premotor-motor connections in de novo Parkinson's disease. Brain (2004) 1.01
Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson disease. Neurology (2011) 0.99
Repetitive transcranial magnetic stimulation causes a short-term increase in the duration of the cortical silent period in patients with Parkinson's disease. Neurosci Lett (2000) 0.96
Repetitive magnetic stimulation of cortical motor areas in Parkinson's disease: implications for the pathophysiology of cortical function. Mov Disord (2002) 0.96
Asymmetric corticomotor excitability correlations in early Parkinson's disease. Mov Disord (2007) 0.91
Repetitive transcranial stimulation for freezing of gait in Parkinson's disease. Mov Disord (2007) 0.91
Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson disease. Neurology (2005) 0.91
Safety study of 50 Hz repetitive transcranial magnetic stimulation in patients with Parkinson's disease. Clin Neurophysiol (2009) 0.90
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry (2006) 11.84
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol (2009) 11.59
Phenomenology and classification of dystonia: a consensus update. Mov Disord (2013) 4.98
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry (2010) 4.85
Identifying true brain interaction from EEG data using the imaginary part of coherency. Clin Neurophysiol (2004) 4.19
Early consolidation in human primary motor cortex. Nature (2002) 3.56
The pathophysiological basis of dystonias. Nat Rev Neurosci (2008) 3.46
Modeling the current distribution during transcranial direct current stimulation. Clin Neurophysiol (2006) 3.39
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
The cerebellum in Parkinson's disease. Brain (2013) 3.06
What is the Bereitschaftspotential? Clin Neurophysiol (2006) 3.02
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry (2010) 2.98
Classification and definition of disorders causing hypertonia in childhood. Pediatrics (2003) 2.93
Levodopa in the treatment of Parkinson's disease: current controversies. Mov Disord (2004) 2.90
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry (2012) 2.74
Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol (2011) 2.65
Repetitive transcranial magnetic stimulation-induced corticomotor excitability and associated motor skill acquisition in chronic stroke. Stroke (2006) 2.63
Regional homogeneity changes in patients with Parkinson's disease. Hum Brain Mapp (2009) 2.42
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study. Neuropsychopharmacology (2012) 2.17
What does the ratio of injected current to electrode area tell us about current density in the brain during tDCS? Clin Neurophysiol (2009) 2.17
Transcranial magnetic stimulation of the brain: guidelines for pain treatment research. Pain (2015) 2.11
Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry (2006) 2.09
A functional MRI study of automatic movements in patients with Parkinson's disease. Brain (2005) 2.09
Emotional stimuli and motor conversion disorder. Brain (2010) 2.06
Multimodal imaging of brain reorganization in motor areas of the contralesional hemisphere of well recovered patients after capsular stroke. Brain (2005) 2.03
Psychopathology and psychogenic movement disorders. Mov Disord (2011) 2.02
Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device. Mov Disord (2009) 2.00
Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain (2012) 1.99
Improving hand function in chronic stroke. Arch Neurol (2002) 1.95
How self-initiated memorized movements become automatic: a functional MRI study. J Neurophysiol (2003) 1.93
Transcranial direct current stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry (2010) 1.93
Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry (2004) 1.92
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol (2008) 1.87
Functional properties of brain areas associated with motor execution and imagery. J Neurophysiol (2003) 1.86
Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron (2010) 1.85
Constraint-induced therapy in stroke: magnetic-stimulation motor maps and cerebral activation. Neurorehabil Neural Repair (2003) 1.83
Do primary adult-onset focal dystonias share aetiological factors? Brain (2007) 1.83
A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry (2006) 1.83
A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression. Biol Psychiatry (2012) 1.76
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord (2007) 1.74
Motor planning, imagery, and execution in the distributed motor network: a time-course study with functional MRI. Cereb Cortex (2008) 1.72
Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry (2003) 1.72
Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. Biol Psychiatry (2008) 1.71
Increased midbrain gray matter in Tourette's syndrome. Ann Neurol (2006) 1.69
Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry (2003) 1.68
Virtual reality-induced cortical reorganization and associated locomotor recovery in chronic stroke: an experimenter-blind randomized study. Stroke (2005) 1.68
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry (2005) 1.65
Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) (2009) 1.62
The focal dystonias: current views and challenges for future research. Mov Disord (2013) 1.62
Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci (2004) 1.61
Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. J Clin Psychiatry (2008) 1.57
Residual brain dysfunction observed one year post-mild traumatic brain injury: combined EEG and balance study. Clin Neurophysiol (2012) 1.55
Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects. Am J Psychiatry (2005) 1.55
Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol (2004) 1.54
Consensus paper: combining transcranial stimulation with neuroimaging. Brain Stimul (2009) 1.54
Metabolic alterations in corpus callosum may compromise brain functional connectivity in MTBI patients: an 1H-MRS study. Neurosci Lett (2011) 1.51
Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biol Psychiatry (2005) 1.51
Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry (2010) 1.51
Repetitive transcranial magnetic stimulation or transcranial direct current stimulation? Brain Stimul (2009) 1.49
What we think before a voluntary movement. J Cogn Neurosci (2013) 1.48
Contribution of the ipsilateral motor cortex to recovery after chronic stroke. Ann Neurol (2003) 1.48
Alteration of brain default network in subacute phase of injury in concussed individuals: resting-state fMRI study. Neuroimage (2011) 1.48
Neural correlates of cross-modal binding. Nat Neurosci (2003) 1.48
Psychiatric symptoms associated with focal hand dystonia. Mov Disord (2010) 1.47
Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry (2012) 1.47
Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor. Mov Disord (2011) 1.47
Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord (2007) 1.46
Surround inhibition in human motor system. Exp Brain Res (2004) 1.45
Linear and nonlinear information flow based on time-delayed mutual information method and its application to corticomuscular interaction. Clin Neurophysiol (2009) 1.45
Emerging concepts in the physiological basis of dystonia. Mov Disord (2013) 1.45
Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry (2005) 1.44
The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. Brain (2011) 1.44
Effective connectivity of brain networks during self-initiated movement in Parkinson's disease. Neuroimage (2010) 1.44
Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry (2003) 1.44
Disturbed surround inhibition in focal hand dystonia. Ann Neurol (2004) 1.43
Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry (2008) 1.42
Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study. Brain (2007) 1.40
Kinematic improvement following Botulinum Toxin-A injection in upper-limb spasticity due to stroke. J Neurol Neurosurg Psychiatry (2009) 1.40
The influence of normal human ageing on automatic movements. J Physiol (2004) 1.40
Reporting clinical trials: full access to all of the data. Arch Neurol (2002) 1.39
Definition and classification of hyperkinetic movements in childhood. Mov Disord (2010) 1.38
Cerebral blood flow in immediate and sustained anxiety. J Neurosci (2007) 1.38
Prediction of human voluntary movement before it occurs. Clin Neurophysiol (2010) 1.36
Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology (2003) 1.36
Short intracortical and surround inhibition are selectively reduced during movement initiation in focal hand dystonia. J Neurosci (2008) 1.35
Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. J Nucl Med (2008) 1.32
Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression. Biol Psychiatry (2013) 1.31
Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg (2008) 1.31
Functional connectivity of cortical motor areas in the resting state in Parkinson's disease. Hum Brain Mapp (2010) 1.30
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry (2004) 1.29
Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain (2006) 1.29
Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder. Pediatrics (2006) 1.29
The electric field induced in the brain by magnetic stimulation: a 3-D finite-element analysis of the effect of tissue heterogeneity and anisotropy. IEEE Trans Biomed Eng (2003) 1.28
A coil design for transcranial magnetic stimulation of deep brain regions. J Clin Neurophysiol (2002) 1.28
Neural correlates of bimanual anti-phase and in-phase movements in Parkinson's disease. Brain (2010) 1.28
Modifications of the interactions in the motor networks when a movement becomes automatic. J Physiol (2008) 1.28
Screening questionnaire before TMS: an update. Clin Neurophysiol (2011) 1.27